Workers comp insurers under pressure to reimburse MED
Claims Journal dives into a new paper from the National Institute for Occupational Safety and Health and the Workers’ Compensation Research Institute on the complex issues at the intersection of MED and workers comp insurance.
Some interesting nuggets:
- Insurers are cutting their spending on opioids with the help of stricter regulations.
- At present, only six states allow or require insurers to reimburse workers comp claimants for MED.
- The paper cites a 2017 National Academy of Sciences review that only supported cannabinoids as a therapy for three conditions: chronic neuropathic and end-of-life pain, spasticity due to multiple sclerosis or spinal cord injury, and for the control of nausea caused by chemotherapy.
- “Nevertheless, anecdotal evidence has persuaded many physicians that therapeutic use of marijuana is justified.”
- A Pennsylvania claimants attorney said some insurers are eager to cover MED since they won’t have to cover medication for opioids’ side effects.